拓新药业发预亏，预计2025年度归母净亏损5400万元–7300万元
Tuoxin Pharmaceutical Tuoxin Pharmaceutical (SZ:301089) Zhi Tong Cai Jing·2026-01-23 11:24

Group 1 - The company, Tuoxin Pharmaceutical (301089.SZ), has disclosed its performance forecast for the year 2025, expecting a net loss attributable to shareholders of between 54 million and 73 million yuan [1] - The net loss after deducting non-recurring gains and losses is projected to be between 62 million and 84 million yuan [1]